Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for Amyris?
Amyris's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.926. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Amyris's stock?
Currently, 1 analysts cover Amyris's stock, with a consensus target price of $1.50. Analyst ratings provide insights into the stock's expected performance.
What is Amyris's revenue over the trailing twelve months?
Over the trailing twelve months, Amyris reported a revenue of $268.22M.
What is the EBITDA for Amyris?
Amyris's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$538.15M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Amyris?
Amyris has a free cash flow of -$540.46M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Amyris have, and what sector and industry does it belong to?
Amyris employs approximately 1,598 people. It operates in the Materials sector, specifically within the Chemicals: Specialty industry.
Financials
- EPS (TTM)
- -$1.926
- Revenue (TTM)
- $268.22M
- EBITDA (TTM)
- -$538.15M
- Free Cashflow (TTM)
- -$540.46M
Pricing
- 52W span
- $0.0005402$0.00645
Analyst Ratings
The price target is $1.50 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to the health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.
- Employees
- 1,598
- Industries
- Chemicals: Specialty
- Sector
- Materials
Identifier
- ISIN
- US03236M2008
- Primary Ticker
- AMRSQ
Finance data from FactSet